Cerebral Palsy Research Network Blog

_NINDS CDE


Field Value
CDE ID C11965
CDE Name Tardieu Scale movement resistance score
Variable Name TardieuScaleMovmntResistScore
Definition

The semi-quantitative score describing relative resistance to passive limb movement or occurrence of spasticity observed while administering the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject.

Description

No resistance throughout the course of the passive movement;Slight resistance throughout the course of passive movement, no clear catch at a precise angle;Clear catch at a precise angle, interrupting the passive movement, followed by release;Fatigable clonus with less than 10 seconds when maintaining the pressure and appearing at the precise angle;Unfatigable clonus with more than 10 seconds when maintaining the pressure and appearing at a precise angle;Joint is immovable (Indicate which assistive device the participant uses);

Instructions

Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.

Input Restrictions Single Pre-Defined Value Selected
Permissible Values

0;1;2;3;4;5;

Question Text X
Data Type Numeric Values
Population Adult, Pediatric
Measurement Type
Field Size
Minimum Value
Maximum Value
Domain Outcomes and End Points
SubDomain Spasticity/Movement
CRF Module Tardieu Scale
Alias Aliases for variable name not defined
Classification Exploratory
Copyright/Trademark
Previous Title Tardieu Scale Q2
References

Key Reference:
Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.
Other References:
Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012.
Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.
Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.
Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.
Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.

CA DSR ID
CDISC ID
LOINC ID
SNOMED
Version Date 2013-07-22T16:57:17.79
Version Number 3